Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Veru Inc. (VERU : NSDQ)

• Company Description    Veru Inc. engages in the development, manufacture and marketing of consumer health care products. It focuses on producing FC2 female condom which provides dual protection against unintended pregnancy and sexually transmitted infections. Veru Inc., formerly known as The Female Health Company, is headquartered in Miami, FL. Number of Employees: 210

• Price / Volume Information    Yesterday's Closing Price: $3.45 Daily Weekly Monthly 20 Day Moving Average: 131,931 shares Shares Outstanding: 14.66 (millions) Market Capitalization: $50.57 (millions) Beta: -0.74 52 Week High: $14.20 52 Week Low: $2.64 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -7.01% -8.64% 12 Week -42.88% -48.12% Year To Date -46.96% -51.14%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 2916 N. Miami Avenue Suite 1000 - Miami,FL 33127 USA ph: 305-509-6897 fax: 312-595-9122 veruinvestor@verupharma.com http://www.veruhealthcare.com

• General Corporate Information    Officers Mitchell S.Steiner - Chairman; Chief Executive Officer and President Michele Greco - Chief Financial Officer and Chief Administrative O Harry Fisch - Vice Chairman Grace S. Hyun - Director Lucy Lu - Director Peer Information Veru Inc. (BJCT) Veru Inc. (CADMQ) Veru Inc. (APNO) Veru Inc. (UPDC) Veru Inc. (IMTIQ) Veru Inc. (CYGN) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED PRODUCTS Sector: Medical CUSIP: 92536C202 SIC: 2834 Fiscal Year Fiscal Year End: September Last Reported Quarter: 06/01/25 Next Expected EPS Date: 12/15/25 Share - Related Items Shares Outstanding: 14.66 Most Recent Split Date: 8.00 (0.10:1) Beta: -0.74 Market Capitalization: $50.57 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.49 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-2.25 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 2.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 12/15/25

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 3.30 Price/Cash Flow: - Price / Sales: 2.99 EPS Growth vs. Year Ago Period: 28.57% vs. Previous Quarter: 0.00% Sales Growth vs. Year Ago Period: 72.37% vs. Previous Quarter: 68.36% ROE 06/30/25 - -143.24 03/31/25 - -128.51 12/31/24 - -112.75 ROA 06/30/25 - -85.22 03/31/25 - -76.51 12/31/24 - -67.54 Current Ratio 06/30/25 - 2.42 03/31/25 - 3.80 12/31/24 - 4.47 Quick Ratio 06/30/25 - 2.42 03/31/25 - 3.80 12/31/24 - 4.47 Operating Margin 06/30/25 - - 03/31/25 - - 12/31/24 - - Net Margin 06/30/25 - - 03/31/25 - - 12/31/24 - - Pre-Tax Margin 06/30/25 - -410.86 03/31/25 - -286.19 12/31/24 - -211.71 Book Value 06/30/25 - 1.05 03/31/25 - 1.44 12/31/24 - 1.82 Inventory Turnover 06/30/25 - 10.65 03/31/25 - 4.86 12/31/24 - 3.18 Debt-to-Equity 06/30/25 - 0.00 03/31/25 - 0.00 12/31/24 - 0.00 Debt-to-Capital 06/30/25 - 0.00 03/31/25 - 0.00 12/31/24 - 0.00

Powered by Zacks Investment Research ©